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I S S N 0 7 3 5 - 1 0 9 7Vascular imaging with 18F-ﬂuorodeoxyglucose posi-
tron emission tomography (18FDG-PET) provides a
noninvasive surrogate of inﬂammation and has been
used to test novel drug treatments for atherosclerosis
(1). Hypoxia exists in atherosclerosis (2) and may
contribute to the measured FDG signal (3). 18F-ﬂuo-
romisonidazole (FMISO) PET can quantify hypoxia
in tumors; it has not been applied to human
atherosclerosis.
Our hypotheses were: 1) carotid plaques that cause
transient ischemic attack (TIA) or stroke are more
hypoxic than contralateral asymptomatic plaques;
2) carotid FDG and FMISO PET signals are positively
correlated; and 3) carotid FMISO PET signal positively
correlates with plaque hypoxia-inducible factor-1a
(HIF-1a) staining.
Sixteen participants with carotid atherosclerosis
(mean age 70  7 years; 69% male; 8 recently symp-
tomatic) underwent computed tomography (CT)
angiography and PET/CT imaging with FDG (250 MBq)
and FMISO (300 MBq). FMISO PET imaging occurred
within 2  1 days of FDG PET imaging, and symp-
tomatic individuals underwent imaging 16  11 days
after TIA/stroke.
Dynamic imaging of FMISO (120 to 180 min after
tracer injection) allowed estimation of both the
mean Ki (net inﬂux rate constant) and mean of
maximum target-to-background ratio (mean max
TBR) (derived from the ﬁnal 3 acquisition frames
165 to 180 min post-injection). Carotid endarterec-
tomy was performed a median of 6 days (range: 3
to 15 days) after imaging. Eleven plaques were
processed for immunohistochemistry: mean per-
centage area CD68 and a-smooth muscle actin
staining; mean CD31 staining/mm2; and numbers of
HIF-1a nuclei.Mean max TBR of FMISO was signiﬁcantly greater
in symptomatic plaques than that in contralateral
lesions (1.11  0.07 vs. 1.05  0.06; p <0.05) (Figure 1).
Mean Ki in symptomatic plaques was also signiﬁ-
cantly higher than that in asymptomatic plaques
(3.6  104  2.9  104 min1 vs. 1.6  104  1.6 
104 min1; p ¼ 0.03). FMISO uptake correlated
positively with FDG (TBR: r ¼ 0.51; p < 0.01 and mean
Ki: r ¼ 0.43; p ¼ 0.02). FDG uptake and plaque
macrophage content were strongly related (r ¼ 0.67;
p ¼ 0.02). There was a trend to a positive correlation
between FMISO and plaque macrophages (r ¼ 0.52;
p ¼ 0.10). There was no relationship between FMISO
uptake and risk factors for atherosclerosis, plaque
smooth muscle content, or numbers of positively
stained nuclei for HIF-1a. There was a trend to a
negative correlation between the FMISO signal and
CD31 staining (r ¼ 0.62; p ¼ 0.08).
In summary, our ﬁrst and second hypotheses were
proven: 1) culprit carotid plaques after TIA or stroke
are more hypoxic than asymptomatic lesions, and
2) plaque hypoxia makes a signiﬁcant contribution to
carotid artery FDG PET signals. The third hypothesis,
linking imaging and a tissue marker of hypoxia, was
not proven.
Hypoxia has been linked with adverse features of
plaque biology, including inﬂammation and intra-
plaque hemorrhage (2). Furthermore, inﬂammatory
stimuli increase glycolytic ﬂux in macrophages, and
this effect is ampliﬁed in hypoxic conditions (4). We
now suggest that hypoxia is more common in symp-
tomatic lesions.
The robust correlation between FDG and FMISO
signals suggests that hypoxia contributes to the
FDG signal in FDG PET studies of atherosclerosis.
In a pilot study using a related PET hypoxia
tracer, HX-4, van der Valk et al. (5) drew similar
conclusions (r ¼ 0.75; p ¼ 0.03). We extended this
result using a better validated tracer and a larger
patient cohort; the congruence of both static and
dynamic measures of hypoxia further supports our
conclusions.
The principal study limitation was the sample size.
Caution should be used in the interpretation of data
other than those regarding our a priori hypotheses; no
adjustment was made for multiple observations
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FIGURE 1 Imaging of Hypoxia in Carotid Atherosclerosis
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1) Positron emission tomography/computed tomography (PET/CT) imaging of a culprit carotid stenosis after stroke. (A) CT angiography.
Stenosis in the left internal carotid artery (arrow). (B) Fused 18F-ﬂuorodeoxyglucose (FDG) PET/CT. Intense uptake in the culprit lesion
(arrow). (C) Fused 18F-ﬂuoromisonidazole (FMISO) PET/CT. Corresponding uptake is indicative of intraplaque hypoxia (arrow). 2) Carotid
uptake of FDG and FMISO are positively correlated. Mean max TBR ¼ mean of maximum target-to-background ratio.
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1874within individuals. Tissue ﬁxation methods might
have adversely affected HIF-1a immunohistochem-
istry, although cancer studies also reported conﬂict-
ing results with respect to correlations between
hypoxia imaging and HIF-1a. Nevertheless, we hope
these data stimulate further study into hypoxia and
markers of plaque destabilization.
We reported the ﬁrst prospective human study to
quantify hypoxia in atherosclerosis using the vali-
dated PET tracer, FMISO. Symptomatic carotid
plaques were more hypoxic than asymptomatic
lesions, perhaps identifying a novel target for drug
therapy. The correlation between FDG and FMISO
suggested that hypoxia contributes to the FDG signal
in atherosclerosis PET studies.Francis R. Joshi, MD, PhD
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